Literature DB >> 21076304

Diagnosis and management of pituitary adenomas.

Ranee R Lleva1, Silvio E Inzucchi.   

Abstract

PURPOSE OF REVIEW: Pituitary adenomas are frequently encountered in practice either because of clinical symptoms or as incidental findings. These tumors may alter pituitary function and can therefore have a considerable impact on morbidity, mortality, and quality of life. RECENT
FINDINGS: The presentation is variable for each type of tumor, with microadenomas being either silent or manifesting with symptoms of hormonal excess. In contrast, macroadenomas may present with mass effect. The various histologic types include prolactinomas, nonfunctioning adenomas, somatotropinomas, corticotropinomas, and thyrotropinomas. The present article will serve as an update on the diagnosis and treatment of pituitary adenomas. Advances in medical management for each tumor are discussed, highlighting new therapeutic alternatives. The role of surgery is also reviewed. Recommendations on the surveillance and postoperative monitoring of patients are emphasized.
SUMMARY: Newer methods in the diagnosis and treatment for pituitary adenomas greatly expand our ability to care for affected patients.

Entities:  

Mesh:

Year:  2011        PMID: 21076304     DOI: 10.1097/CCO.0b013e328341000f

Source DB:  PubMed          Journal:  Curr Opin Oncol        ISSN: 1040-8746            Impact factor:   3.645


  8 in total

Review 1.  Diagnosis and Management of pituitary disease with focus on the role of Magnetic Resonance Imaging.

Authors:  Amit Mahajan; Richard A Bronen; Ali Y Mian; Sacit Bulent Omay; Dennis D Spencer; Silvio E Inzucchi
Journal:  Endocrine       Date:  2020-03-11       Impact factor: 3.633

2.  Setup margins and geometric uncertainties in intensity-modulated radiation therapy in treating pituitary adenomas: the experience of Lyon Sud Hospital.

Authors:  B De Bari; I Shakir Shakir; T Chekrine; L Lestrade; V Favrel
Journal:  Radiol Med       Date:  2012-10-22       Impact factor: 3.469

Review 3.  Pituitary metastasis of thyroid cancer.

Authors:  Daniele Barbaro; Nicola Desogus; Giuseppe Boni
Journal:  Endocrine       Date:  2012-09-26       Impact factor: 3.633

4.  Risk factors and the prognosis of sexual dysfunction in male patients with pituitary adenomas: a multivariate analysis.

Authors:  Wen-Jian-Long Zhou; Shun-Chang Ma; Min Zhao; Chang Liu; Xiu-Dong Guan; Zhao-Shi Bao; Gui-Jun Jia; Wang Jia
Journal:  Asian J Androl       Date:  2018 Jan-Feb       Impact factor: 3.285

Review 5.  The Mechanism and Pathways of Dopamine and Dopamine Agonists in Prolactinomas.

Authors:  Xiaoshuang Liu; Chao Tang; Guodao Wen; Chunyu Zhong; Jin Yang; Junhao Zhu; Chiyuan Ma
Journal:  Front Endocrinol (Lausanne)       Date:  2019-01-22       Impact factor: 5.555

6.  Impacts of Surgery on Symptom Burden and Quality of Life in Pituitary Tumor Patients in the Subacute Post-operative Period.

Authors:  Mark R Waddle; Mollie D Oudenhoven; Casey V Farin; Allison M Deal; Riane Hoffman; Hojin Yang; Jennifer Peterson; Terri S Armstrong; Matthew G Ewend; Jing Wu
Journal:  Front Oncol       Date:  2019-04-23       Impact factor: 6.244

Review 7.  Hypogonadism in Male Patients with Pituitary Adenoma and Its Related Mechanism: A Review of Literature.

Authors:  Zisheng Yan; Ting Lei
Journal:  Brain Sci       Date:  2022-06-17

8.  Fetal Alcohol Exposure Reduces Dopamine Receptor D2 and Increases Pituitary Weight and Prolactin Production via Epigenetic Mechanisms.

Authors:  Omkaram Gangisetty; Olivia Wynne; Shaima Jabbar; Cara Nasello; Dipak K Sarkar
Journal:  PLoS One       Date:  2015-10-28       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.